These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 5594869

  • 1. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
    Ertogan F.
    Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
    [No Abstract] [Full Text] [Related]

  • 2. [Mucolytic and mucoregulatory agents].
    Yernault JC.
    Rev Med Brux; 1987 Oct; 8(8):423. PubMed ID: 3423520
    [No Abstract] [Full Text] [Related]

  • 3. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK.
    Paediatr Respir Rev; 2006 Oct; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [Abstract] [Full Text] [Related]

  • 4. [Clinical testing of a new cough remedy in children].
    Hartung G.
    Hippokrates; 1969 Apr 15; 40(7):277-8. PubMed ID: 5801838
    [No Abstract] [Full Text] [Related]

  • 5. [Secretolysis through gelomyrtol].
    Kurz JF.
    Z Allgemeinmed; 1970 Nov 20; 46(32):1623-7. PubMed ID: 4934657
    [No Abstract] [Full Text] [Related]

  • 6. [Experience with a combination of auxiloson and bisolvon is diseases of the respiratory tract following multilocular findings].
    Mertens H.
    Z Allgemeinmed; 1969 Sep 20; 45(26):1222-5. PubMed ID: 5374621
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical study of ucb 3983 in pediatric (author's transl)].
    Goffart P.
    Acta Paediatr Belg; 1973 Sep 20; 27(4):257-62. PubMed ID: 4358847
    [No Abstract] [Full Text] [Related]

  • 8. Theory and practice of the use of expectorants reviewed from clinical aspects.
    Nagy G.
    Ther Hung; 1984 Sep 20; 32(1):6-12. PubMed ID: 6400475
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B.
    Novartis Found Symp; 2002 Sep 20; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [Abstract] [Full Text] [Related]

  • 10. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M, Kuna P.
    Pol Merkur Lekarski; 2002 Mar 20; 12(69):245-7. PubMed ID: 12053600
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of affections of the respiratory organs in heart diseases using Bisolvon and Auxiloson in a dose inhaler].
    Guttmann W.
    Hippokrates; 1968 Feb 29; 39(4):147-9. PubMed ID: 5712074
    [No Abstract] [Full Text] [Related]

  • 12. [6 years of therapy with Bisolvon].
    Günthner W.
    Ther Ggw; 1970 Jan 29; 109(1):34 passim. PubMed ID: 4910104
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of the properties of Bisolvon in the therapy of respiratory diseases in children].
    Vendemmia S, Maurino G, Goglia R, Della Peruta A.
    Minerva Pediatr; 1981 Mar 15; 33(5):227-31. PubMed ID: 7242493
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trial of a new mucolytic, s-carboxymethylcysteine].
    Ghillione de Torviso S.
    Arch Argent Pediatr; 1971 Aug 15; 69(6):247-8. PubMed ID: 4941345
    [No Abstract] [Full Text] [Related]

  • 15. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF.
    Respir Care; 2007 Sep 15; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [Abstract] [Full Text] [Related]

  • 16. [Our experience in the use in pediatrics of a new antispastic drug].
    Chiossi FM, Tassara A.
    Minerva Pediatr; 1968 Oct 06; 20(40):2111-5. PubMed ID: 5746684
    [No Abstract] [Full Text] [Related]

  • 17. Management of mucus hypersecretion.
    Clarke SW.
    Eur J Respir Dis Suppl; 1987 Oct 06; 153():136-44. PubMed ID: 3322858
    [Abstract] [Full Text] [Related]

  • 18. [Expectorants in the therapy of respiratory disease].
    Ther Umsch; 1965 Jul 06; 22(7):392-402. PubMed ID: 5834882
    [No Abstract] [Full Text] [Related]

  • 19. [Josamycin in streptococcal infections and pertussis].
    Cascio G, Titone L, Portelli V, Castello G.
    G Ital Chemioter; 1982 Jul 06; 29 Suppl 1():135-9. PubMed ID: 6927110
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.